• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常见牙龈放线菌病继发于异基因造血干细胞移植后:病例报告。

Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report.

机构信息

Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, SP, Brazil.

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

BMC Oral Health. 2023 Feb 2;23(1):62. doi: 10.1186/s12903-023-02777-7.

DOI:10.1186/s12903-023-02777-7
PMID:36732789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9893679/
Abstract

BACKGROUND

Allogeneic hematopoietic stem cell transplant (allo-HSCT) is used to treat several hematological diseases, but immunosuppression during allo-HSCT facilitates opportunistic microbial growth in tissues, such as actinomycosis. An effective diagnosis of opportunistic diseases is essential for correct management of the disease and preservation of the immunosuppressed patient's life.

CASE DESCRIPTION

A 57-year-old female patient was diagnosed with extranodal nasal type NK/T cell lymphoma and underwent curative treatment with allo-HSCT. Twenty-one days after the last clinical follow-up, the patient presented a necrotizing lesion in the papilla region between the first and second molars of the second quadrant. Histopathological analysis showed the presence of a bacterial cluster consistent with Actinomyces infection, and a dense lymphoid infiltrate was also observed. Immunohistochemistry for CD20, CD3, and CD56 was performed to exclude the possibility of the recurrence of extranodal NK/T cell lymphoma. Oral microbiota profiling showed a huge increase in the abundance of Actinomyces bacteria in the subgingival region three weeks prior to appearance of the lesion.

CONCLUSIONS

Opportunistic infections with an unusual clinical appearance are confounding factors in therapeutic decision-making. We present for the first time a case of actinomycosis in the gingival papilla region following allo-HSCT. We also highlight how microbiota profiling through next-generation sequencing could be used to anticipate bacterial infection diagnosis.

摘要

背景

异基因造血干细胞移植(allo-HSCT)用于治疗多种血液系统疾病,但 allo-HSCT 期间的免疫抑制会促进放线菌等机会性微生物在组织中生长。对机会性疾病进行有效诊断对于正确管理疾病和保护免疫抑制患者的生命至关重要。

病例描述

一名 57 岁女性患者被诊断为结外鼻型 NK/T 细胞淋巴瘤,并接受 allo-HSCT 治愈性治疗。在最后一次临床随访后 21 天,患者出现第二象限第二磨牙和第一磨牙之间的乳突区坏死性病变。组织病理学分析显示存在一致的细菌簇,符合放线菌感染,还观察到密集的淋巴样浸润。进行 CD20、CD3 和 CD56 的免疫组化检查以排除结外 NK/T 细胞淋巴瘤复发的可能性。口腔微生物组分析显示,在病变出现前三周,龈下区域放线菌的丰度大量增加。

结论

具有不寻常临床表现的机会性感染是治疗决策的混杂因素。我们首次报告了 allo-HSCT 后牙龈乳突区放线菌病的病例。我们还强调了如何通过下一代测序进行微生物组分析来预测细菌感染的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/aa8f44806490/12903_2023_2777_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/b4c688dac949/12903_2023_2777_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/e5e7343eac45/12903_2023_2777_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/80c9a47fb1e3/12903_2023_2777_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/aa8f44806490/12903_2023_2777_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/b4c688dac949/12903_2023_2777_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/e5e7343eac45/12903_2023_2777_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/80c9a47fb1e3/12903_2023_2777_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f6/9893679/aa8f44806490/12903_2023_2777_Fig4_HTML.jpg

相似文献

1
Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report.异常见牙龈放线菌病继发于异基因造血干细胞移植后:病例报告。
BMC Oral Health. 2023 Feb 2;23(1):62. doi: 10.1186/s12903-023-02777-7.
2
Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.异基因造血干细胞移植治疗结外自然杀伤/T 细胞淋巴瘤。
Turk J Haematol. 2021 Jun 1;38(2):126-137. doi: 10.4274/tjh.galenos.2021.2020.0438. Epub 2021 Feb 4.
3
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.首次造血干细胞移植后复发的血液病患者进行第二次造血异体干细胞移植的预后因素:一项单中心研究。
Front Immunol. 2023 Jan 4;13:1066748. doi: 10.3389/fimmu.2022.1066748. eCollection 2022.
4
Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.尽管进行了青霉素预防,异基因造血干细胞移植后仍发生放线菌病。
Transpl Infect Dis. 2016 Aug;18(4):595-600. doi: 10.1111/tid.12549. Epub 2016 Jul 5.
5
Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.移植后自然杀伤细胞计数:异基因造血干细胞移植后急性移植物抗宿主病和生存结局的预测指标
Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):527-535.e2. doi: 10.1016/j.clml.2016.06.013. Epub 2016 Jun 8.
6
Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.儿童异基因造血干细胞移植中急性移植物抗宿主病的微生物群长期动态和预测。
Microbiome. 2021 Jun 28;9(1):148. doi: 10.1186/s40168-021-01100-2.
7
The role of microbiota in allogeneic hematopoietic stem cell transplantation.肠道菌群在异基因造血干细胞移植中的作用。
Expert Opin Biol Ther. 2021 Aug;21(8):1121-1131. doi: 10.1080/14712598.2021.1872541. Epub 2021 Jan 18.
8
Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.异基因造血干细胞移植后儿童与成人移植后淋巴增殖性疾病的危险因素评估比较。
J Clin Pathol. 2021 Nov;74(11):697-703. doi: 10.1136/jclinpath-2021-207492. Epub 2021 May 19.
9
Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.异基因造血干细胞移植作为复发或难治性鼻腔 NK/T 细胞淋巴瘤的挽救策略。
Med Oncol. 2011 Sep;28(3):840-5. doi: 10.1007/s12032-010-9532-1. Epub 2010 Apr 23.
10
Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。
Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.

本文引用的文献

1
Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients.共生口腔微生物群影响异基因干细胞移植受者溃疡性口腔粘膜炎的临床病程。
Sci Rep. 2022 Oct 20;12(1):17527. doi: 10.1038/s41598-022-21775-3.
2
Pulmonary Infection: Case Report and Review of the Literature.肺部感染:病例报告及文献综述
Front Med (Lausanne). 2022 Jun 10;9:916817. doi: 10.3389/fmed.2022.916817. eCollection 2022.
3
Prediction models for early diagnosis of actinomycotic osteomyelitis of the jaw using machine learning techniques: a preliminary study.
基于机器学习技术的下颌放线菌性骨髓炎早期诊断预测模型:初步研究。
BMC Oral Health. 2022 May 6;22(1):164. doi: 10.1186/s12903-022-02201-6.
4
Clinical utility of oral management in allogeneic hematopoietic stem cell transplantation recipients: microbiological evidence based on molecular analysis of oral bacteria.异基因造血干细胞移植受者口腔管理的临床实用性:基于口腔细菌分子分析的微生物学证据。
Support Care Cancer. 2022 Jan;30(1):757-764. doi: 10.1007/s00520-021-06462-9. Epub 2021 Aug 10.
5
Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft--Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.口腔生物膜微生物群失调与异基因造血干细胞移植后急性移植物抗宿主病的风险相关。
Front Immunol. 2021 Jun 18;12:692225. doi: 10.3389/fimmu.2021.692225. eCollection 2021.
6
Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters.牙周治疗中益生菌替代洗必泰的研究:临床和微生物学参数评估
Microorganisms. 2020 Dec 29;9(1):69. doi: 10.3390/microorganisms9010069.
7
Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.尽管进行了青霉素预防,异基因造血干细胞移植后仍发生放线菌病。
Transpl Infect Dis. 2016 Aug;18(4):595-600. doi: 10.1111/tid.12549. Epub 2016 Jul 5.
8
Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).血液肿瘤患者及造血干细胞移植受者的基础口腔护理:癌症支持治疗多国协会/国际口腔肿瘤学会(MASCC/ISOO)与欧洲血液和骨髓移植学会(EBMT)联合工作组的立场文件
Support Care Cancer. 2015 Jan;23(1):223-36. doi: 10.1007/s00520-014-2378-x. Epub 2014 Sep 5.
9
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.放线菌病:病因、临床特征、诊断、治疗和管理。
Infect Drug Resist. 2014 Jul 5;7:183-97. doi: 10.2147/IDR.S39601. eCollection 2014.
10
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples.基于 7 个口腔表面、扁桃体、咽喉和粪便样本的成人消化道细菌微生物组的组成。
Genome Biol. 2012 Jun 14;13(6):R42. doi: 10.1186/gb-2012-13-6-r42.